Insiders · PHAT

PHAT insider transactions

Phathom Pharmaceuticals Inc. (PHAT) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for PHAT

• 11d
  Director Parikh Asit received a gift of 28,000 shares and gifted 28,000 shares, decreasing direct ownership by 54% to 24,122 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 17d
  Director Parikh Asit was granted 24,122 shares and exercised 17,500 shares at a strike of $4.95, increasing direct ownership by 396% to 52,122 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 17d
  Director Fields Heidi was granted 24,122 shares, increasing direct ownership by 80% to 54,122 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 17d
  Director Topper James N was granted 24,122 shares, increasing direct ownership by 57% to 66,718 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 17d
  Director Stenhouse Mark was granted 24,122 shares, increasing direct ownership by 80% to 54,122 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 17d
  Director Schroeder Theodore R was granted 24,122 shares, increasing direct ownership by 115% to 45,122 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 17d
  Director Cola Michael F was granted 24,122 shares, increasing direct ownership by 61% to 63,920 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 17d
  Director Karbe Frank was granted 24,122 shares, increasing direct ownership by 36% to 91,622 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 88d
  SEC Form 4 filed by Phathom Pharmaceuticals Inc.

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 96d
  Principal Accounting Officer Breedlove Robert Charles was granted 15,790 shares and covered exercise/tax liability with 1,378 shares, increasing direct ownership by 31% to 61,480 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 115d
  Chief Legal Off. & Corp. Sec. Cook Anne Marie was granted 3,461 shares and covered exercise/tax liability with 1,535 shares, increasing direct ownership by 2% to 88,660 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 115d
  President and CEO Basta Steven L was granted 12,362 shares and covered exercise/tax liability with 6,277 shares, increasing direct ownership by 2% to 373,315 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 131d
  Director Parikh Asit gifted 80,500 shares and received a gift of 80,500 shares, decreasing direct ownership by 61% to 50,500 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 135d
  Principal Accounting Officer Breedlove Robert Charles covered exercise/tax liability with 776 shares, decreasing direct ownership by 2% to 47,068 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 143d
  Director Parikh Asit exercised 8,750 shares at a strike of $10.30, increasing direct ownership by 7% to 131,000 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 156d
  President and CEO Basta Steven L was granted 251,034 shares, increasing direct ownership by 221% to 364,820 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 156d
  Chief Legal Off. & Corp. Sec. Cook Anne Marie was granted 75,345 shares, increasing direct ownership by 779% to 85,012 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 156d
  Chief Financial & Bus. Officer Narula Sanjeev was granted 82,715 shares, increasing direct ownership by 57% to 226,715 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 166d
  Director Parikh Asit exercised 8,750 shares at a strike of $10.30, increasing direct ownership by 8% to 122,250 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 170d
  Principal Accounting Officer Breedlove Robert Charles covered exercise/tax liability with 230 shares, decreasing direct ownership by 0.48% to 47,844 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 170d
  Chief Legal Off. & Corp. Sec. Cook Anne Marie covered exercise/tax liability with 7,703 shares and was granted 17,370 shares (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 170d
  President and CEO Basta Steven L covered exercise/tax liability with 31,502 shares and was granted 62,038 shares, increasing direct ownership by 37% to 113,786 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 187d
  President and CEO Basta Steven L covered exercise/tax liability with 48,375 shares and converted options into 90,000 shares, increasing direct ownership by 100% to 83,250 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 214d
  Principal Accounting Officer Breedlove Robert Charles sold $7,079 worth of shares (524 units at $13.51), decreasing direct ownership by 1% to 47,407 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 242d
  Amendment: Chief Financial & Bus. Officer Narula Sanjeev was granted 144,000 shares (SEC Form 4)

  4/A - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 243d
  SEC Form 4 filed by Chief Financial & Bus. Officer Narula Sanjeev

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 243d
  New insider Narula Sanjeev claimed no ownership of stock in the company (SEC Form 3)

  3 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 254d
  President and CEO Basta Steven L converted options into 90,000 shares and covered exercise/tax liability with 48,375 shares (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 271d
  Principal Accounting Officer Breedlove Robert Charles sold $5,573 worth of shares (461 units at $12.09), decreasing direct ownership by 0.95% to 47,931 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 324d
  Principal Accounting Officer Breedlove Robert Charles sold $14,152 worth of shares (1,692 units at $8.36), decreasing direct ownership by 3% to 48,392 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 348d
  SEC Form 4 filed by Chief Legal Off. & Corp. Sec. Cook Anne Marie

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 348d
  New insider Cook Anne Marie claimed no ownership of stock in the company (SEC Form 3)

  3 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 367d
  Director Karbe Frank was granted 10,500 shares, increasing direct ownership by 18% to 67,500 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 367d
  Director Cola Michael F was granted 10,500 shares, increasing direct ownership by 36% to 39,798 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 367d
  Director Fields Heidi was granted 10,500 shares, increasing direct ownership by 54% to 30,000 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 367d
  Director Topper James N was granted 10,500 shares, increasing direct ownership by 33% to 42,596 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 367d
  Director Stenhouse Mark was granted 10,500 shares, increasing direct ownership by 54% to 30,000 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 367d
  Director Parikh Asit was granted 10,500 shares, increasing direct ownership by 10% to 113,500 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 380d
  Director Topper James N bought $14,609 worth of shares (3,780 units at $3.86) (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 382d
  SEC Form 4 filed by Principal Accounting Officer Breedlove Robert Charles

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 388d
  Director Topper James N bought $24,462 worth of shares (7,420 units at $3.30) (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 390d
  Director Topper James N bought $152,917 worth of shares (48,203 units at $3.17) (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 395d
  Director Parikh Asit bought $24,984 worth of shares (10,000 units at $2.50), increasing direct ownership by 12% to 95,500 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 397d
  New insider Breedlove Robert Charles claimed ownership of 55,192 shares (SEC Form 3)

  3 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 417d
  Director Schroeder Theodore R was granted 21,000 shares (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 417d
  New insider Schroeder Theodore R claimed no ownership of stock in the company (SEC Form 3)

  3 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 425d
  CFO and CBO Henderson Molly sold $16,740 worth of shares (3,678 units at $4.55), decreasing direct ownership by 4% to 89,868 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 430d
  SEC Form 4 filed by President and CEO Basta Steven L

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 430d
  New insider Basta Steven L claimed no ownership of stock in the company (SEC Form 3)

  3 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 443d
  Director Parikh Asit exercised 7,500 shares at a strike of $11.72, increasing direct ownership by 9% to 93,000 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 447d
  Director Parikh Asit bought $44,200 worth of shares (10,000 units at $4.42), increasing direct ownership by 13% to 85,500 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 461d
  SEC Form 4 filed by President and Chief Executive Curran Terrie

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 461d
  CFO and CBO Henderson Molly was granted 72,000 shares, increasing direct ownership by 77% to 165,546 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 461d
  Chief Operating Officer Nabulsi Azmi was granted 79,200 shares, increasing direct ownership by 34% to 312,590 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 500d
  CFO and CBO Henderson Molly sold $43,371 worth of shares (6,583 units at $6.59), decreasing direct ownership by 7% to 93,546 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 500d
  Chief Operating Officer Nabulsi Azmi sold $51,957 worth of shares (7,886 units at $6.59), decreasing direct ownership by 3% to 233,390 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 500d
  President and Chief Executive Curran Terrie sold $125,884 worth of shares (19,109 units at $6.59), decreasing direct ownership by 5% to 360,465 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 534d
  Chief Operating Officer Nabulsi Azmi sold $8,944 worth of shares (1,118 units at $8.00), decreasing direct ownership by 0.47% to 239,303 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 534d
  CFO and CBO Henderson Molly sold $10,328 worth of shares (1,291 units at $8.00), decreasing direct ownership by 1% to 98,156 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 538d
  Director Karbe Frank bought $99,084 worth of shares (12,500 units at $7.93), increasing direct ownership by 28% to 57,000 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)